Benchmark started Abbott Laboratories with a Buy rating and a $145 price target, calling the diversified healthcare company a steady performer in a volatile global environment.

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Find out where the candidates stand on the biggest issues in the Fort Worth area state Senate district. Early voting starts ...

The governor of Texas is calling on the state Department of Public Safety (DPS) to escalate enforcement against smoke shops ...

Broadcom is working with OpenAI to develop and deploy 10 gigawatts of custom artificial-intelligence accelerators, while MP ...

Finance and technology company Odyssey will help design the application process, manage payments and review complaints for ...

China has outlined new curbs on exports of rare earths and related technologies, extending controls over the use of the ...

Founder of Cbdeeme, Toby Street addressed misconceptions about hemp and CBD. The discussion focused on a recent press release ...

The Illinois governor and the Chicago mayor say they won’t back down after threats by President Donald Trump to have them ...

It’s a key step in implementing a ceasefire and the exchange of hostages for Palestinian prisoners brokered by President ...